MX2014012849A - USO INTRAUTERINO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-E N-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA. - Google Patents

USO INTRAUTERINO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-E N-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA.

Info

Publication number
MX2014012849A
MX2014012849A MX2014012849A MX2014012849A MX2014012849A MX 2014012849 A MX2014012849 A MX 2014012849A MX 2014012849 A MX2014012849 A MX 2014012849A MX 2014012849 A MX2014012849 A MX 2014012849A MX 2014012849 A MX2014012849 A MX 2014012849A
Authority
MX
Mexico
Prior art keywords
spirox
methylene
methyl
intrauterine
systems
Prior art date
Application number
MX2014012849A
Other languages
English (en)
Inventor
Norbert Schmees
Harri Jukarainen
Reinhard Nubbemeyer
Lars Röse
Tuula Valo
Katja Prelle
Henriikka Korolainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014012849(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MX2014012849A publication Critical patent/MX2014012849A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención describe el uso intrauterino de 18-metil-15ß,16ß-metilen-19-nor-20-espirox-4-en-3-onas de la fórmula general (1) (ver Fórmula) en la anticoncepción la terapia ginecológica, así como un sistema intrauterino que contiene compuestos de la fórmula 1.
MX2014012849A 2012-04-23 2013-04-19 USO INTRAUTERINO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-E N-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA. MX2014012849A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23
PCT/EP2013/058220 WO2013160213A1 (de) 2012-04-23 2013-04-19 INTRAUTERINE ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN, INTRAUTERINE SYSTEME ENTHALTEND 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE, SOWIE DEREN VERWENDUNG IN DER KONTRAZEPTION UND GYNÄKOLOGISCHEN THERAPIE

Publications (1)

Publication Number Publication Date
MX2014012849A true MX2014012849A (es) 2015-02-05

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012849A MX2014012849A (es) 2012-04-23 2013-04-19 USO INTRAUTERINO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-E N-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA.

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
AU2013254840A1 (en) 2014-11-06
HK1205000A1 (en) 2015-12-11
UY34758A (es) 2013-11-29
CA2871003A1 (en) 2013-10-31
DOP2014000241A (es) 2014-12-31
CU20140121A7 (es) 2014-12-26
AR090799A1 (es) 2014-12-10
MA37444A1 (fr) 2016-11-30
CR20140490A (es) 2014-11-17
CN104254333A (zh) 2014-12-31
ECSP14024250A (es) 2015-12-31
PE20142438A1 (es) 2015-02-01
JP2015514791A (ja) 2015-05-21
WO2013160213A1 (de) 2013-10-31
CO7111255A2 (es) 2014-11-10
TN2014000444A1 (en) 2016-03-30
PH12014502372A1 (en) 2015-01-26
KR20150004807A (ko) 2015-01-13
US20150065472A1 (en) 2015-03-05
BR112014026193A2 (pt) 2017-06-27
EP2841074A1 (de) 2015-03-04
SG11201406582XA (en) 2014-11-27
CL2014002836A1 (es) 2015-03-13
TW201350122A (zh) 2013-12-16
EA201491922A1 (ru) 2015-04-30
IN2014DN07839A (es) 2015-04-24
IL235095A0 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
IN2015DN01156A (es)
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
PH12014502397B1 (en) Pesticidal compositions and processes related thereto
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
PH12014501991B1 (en) Phenicol antibacterials
MX2015008021A (es) Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
PH12016500620A1 (en) Intrauterine delivery system
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
MX2016003725A (es) Compuestos y su uso para la preparacion de agentes de formacion de imagen tau y formulaciones para la formacion de imagen tau.
TN2014000444A1 (en) INTRAUTERINE APPLICATION OF 18-METHYL-15β,16β-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
TN2014000445A1 (en) Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
UA89388U (ru) Применение глюкозамина гидрохлорида как средства, защищающего организм от системного воздействия высоких температур
IN2012DE00937A (es)
UA112315C2 (uk) Внутрішньоматкові системи, пристрої введення пристроїв iud (внутрішньоматкових пристроїв) і пов'язані з ними способи і набори